During the inflammatory activation associated with COVID-19, the vascular imbalance of VWF and ADAMTS13 favors an elevated VWF:AG/ADAMTS13 activity ratio; this shift is implicated in localized endothelial dysfunction of COVID-19 infection (10–13). The gene discussed is RENBP; the disease is COVID-19.